Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
APO E4 (C112R), APO E4 (L28P; C112R)

General Information

Transgene:   The 6.0 kbps promoter fragment was subcloned into the Bam HI/XbaI site of pCMV. A 1.6 kbp fragment containing the human b-globin splice fragment was subcloned.  A cDNA for ApoE3 was reverse transcribed and converted to ApoE4 by site-directed mutagenesis. 

Mutation:   ApoE4 cDNA was mutated at residue 28 from Leu to Pro by site specific mutagenesis.

Promoter:  rat GFAP gene promoter. , The 990 bp ApoE4 fragment was subcloned downstream from GFAP promoter and upstream from the b-globin site.

Mouse strain:     cDNA were microinjected into the male pronuclei of B6D2FI zygote.  Zygotes were reimplanted into pseudopregnant B6CBAFI females.  Crossed twice with wt C57BL/6 mice.

Phenotype

Neuropathological analysis

Homozygous ApoE4(C112R) contained total ApoE proteins 3.5 fold the endogenous ApoE in wt.

Homozygous ApoE4(L28P; C112R) contained total ApoE proteins 2 fold the endogenous ApoE in wt.

Quantitative Western for synaptic proteins, cytoskeletal protein tau, PkC, and APP show no significant change from wt.

Behavioral

In either passive avoidance task and an active avoidance task, neither Tg mice were different from the wt.

Availability

Licensing/academic distribution contact information:

Gerda Huber gerda.huber_trottmann@roche.com

Patents: None

Reference

Primary:

Huber G, Marz W, Martin JR, Malherbe P, Richards JG, Sueoka N, Ohm T, Hoffmann MM. Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R). Neuroscience 2000;101(1):211-8. Abstract.
 

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad